Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study
Drug survival reflects the real-life efficacy and safety of therapeutic agents. Evidence regarding the durability of adjuvant agents in the treatment of pemphigus is sparse. The aims of this study were to investigate the survival of adjuvant agents used to manage patients with pemphigus, and to iden...
Saved in:
Main Authors: | Khalaf Kridin (Author), Christoph M. Hammers (Author), Ralf J. Ludwig (Author), Dana Tzur Bitan (Author), Arnon D. Cohen (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased Risk of Pemphigus among Patients with Psoriasis: A Large-scale Cohort Study
by: Khalaf Kridin, et al.
Published: (2020) -
Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study
by: Dana Tzur Bitan, et al.
Published: (2022) -
Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
by: Katharina Boch, et al.
Published: (2022) -
Epidemiology of Pemphigus
by: Khalaf Kridin, et al.
Published: (2021) -
Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality
by: Khalaf Kridin, et al.
Published: (2017)